Here, we aimed to investigate plasma LCN2 in the context of the differential diagnoses of dementia and its utility as an independent biomarker by analyzing associations with biomarkers of AD-related pathology as well as with clinical data in AD patients. The gene discussed is LCN2; the disease is Alzheimer disease.